AI assistant
AbbVie Inc. — Director's Dealing 2015
Feb 23, 2015
29755_dirs_2015-02-23_0490dff5-c221-497c-afb5-da89259ed4f9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2015-02-19
Reporting Person: GONZALEZ RICHARD A (Director, Chairman of the Board and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-19 | Common stock, $0.01 par value | A | 165590 | $0.00 | Acquired | 551918 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-19 | Option (right to buy) | $58.88 | A | 327290 | Acquired | 2025-02-18 | Common stock (327290) | Direct |
Footnotes
F1: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
F2: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 109,097 on 02/19/2016, 109,096 on 02/19/2017, and 109,097 on 02/19/2018.